Local Tumor Destruction Versus Partial Penectomy for T1a Squamous Cell Carcinoma of the Penis

Letizia Maria Ippolita Jannello1,2,3, Mario de Angelis4,5,6, Carolin Siech4,7

  • 1Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada. letizia.jannello@unimi.it.

PubMed
Abstract

Insights

Local tumor destruction (LTD) offers similar cancer-specific survival as partial penectomy (PP) for early-stage penile cancer. This study found LTD to be a safe and effective alternative for T1aN0M0 squamous cell carcinoma of the penis (SCCP).

Area of Science:

  • Oncology
  • Surgical Oncology
  • Epidemiology

Background:

  • Local tumor destruction (LTD) is an emerging treatment for early penile cancer.
  • Its efficacy compared to standard treatments like partial penectomy (PP) is not well-established in large studies.
  • This study investigates the cancer control outcomes of LTD versus PP in T1aN0M0 squamous cell carcinoma of the penis (SCCP).

Purpose of the Study:

  • To compare cancer-specific mortality (CSM) between LTD and PP for T1aN0M0 SCCP.
  • To evaluate the safety and efficacy of LTD as an alternative treatment option.
  • To address the knowledge gap regarding LTD's effectiveness in large-scale studies.

Main Methods:

  • Utilized the Surveillance, Epidemiology, and End Results (SEER) database (2000-2020).
  • Identified patients with T1aN0M0 SCCP treated with either LTD or PP.
  • Employed cumulative incidence plots and multivariable competing risks regression models, adjusting for other-cause mortality.

Main Results:

  • Analyzed 1,239 patients: 615 (49.6%) received LTD and 624 (50.4%) received PP.
  • 10-year CSM was comparable: 12.4% for LTD versus 13.5% for PP (p=0.8).
  • LTD was not an independent predictor of higher CSM compared to PP (HR 0.99, p=0.97).

Conclusions:

  • LTD demonstrated comparable cancer-specific mortality rates to PP in T1aN0M0 SCCP.
  • The study supports LTD as a safe alternative to PP based on cancer control outcomes.
  • LTD may be a viable option for managing early-stage penile cancer.

Related Concept Videos